Published in J Thromb Haemost on September 01, 2006
Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J Thromb Haemost (2008) 1.26
Complexity of complement activation in sepsis. J Cell Mol Med (2008) 1.26
Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol (2010) 1.24
Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J (2011) 1.17
Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol (2011) 1.10
Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J Immunol (2010) 0.98
The contribution of gC1qR/p33 in infection and inflammation. Immunobiology (2007) 0.97
Abnormal platelet function in C3-deficient mice. J Thromb Haemost (2009) 0.96
Platelets in inflammation and atherogenesis. Front Immunol (2015) 0.94
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura. Br J Haematol (2009) 0.94
Expression of complement components and inhibitors on platelet microparticles. Platelets (2008) 0.92
Platelet mediated complement activation. Adv Exp Med Biol (2008) 0.88
Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O). J Immunol (2013) 0.87
Regulated complement deposition on the surface of human endothelial cells: effect of tobacco smoke and shear stress. Thromb Res (2007) 0.87
Classical pathway complement activation on human endothelial cells. Mol Immunol (2006) 0.87
Properdin: a tightly regulated critical inflammatory modulator. Immunol Rev (2016) 0.85
Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets. PLoS One (2011) 0.84
Platelets and Their Interactions with Other Immune Cells. Compr Physiol (2015) 0.83
Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood (2017) 0.81
Complement activation: an emerging player in the pathogenesis of cardiovascular disease. Scientifica (Cairo) (2012) 0.80
The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis. Front Pediatr (2016) 0.79
Complement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pH. Front Immunol (2015) 0.79
Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18. Thromb Haemost (2015) 0.78
Properdin-Mediated C5a Production Enhances Stable Binding of Platelets to Granulocytes in Human Whole Blood. J Immunol (2016) 0.78
Minor Role of Plasminogen in Complement Activation on Cell Surfaces. PLoS One (2015) 0.75
Complement and clot. Blood (2017) 0.75
Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR. Front Immunol (2016) 0.75
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med (2001) 4.54
Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med (1981) 1.98
gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J (2000) 1.73
Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines. J Lab Clin Med (1999) 1.67
Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect Immun (2000) 1.56
Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc Natl Acad Sci U S A (1996) 1.34
Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin Immunol Immunopathol (1992) 1.33
Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest (1983) 1.32
Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest (1985) 1.31
The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor. J Biol Chem (1996) 1.27
Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol (1983) 1.25
C3e: an acidic fragment of human C3 with leukocytosis-inducing activity. J Immunol (1979) 1.24
Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol (1994) 1.22
Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. J Exp Med (1984) 1.16
Protein kinase C [micro] is regulated by the multifunctional chaperon protein p32. J Biol Chem (2000) 1.15
Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages. Ann Oncol (2012) 1.13
Isolation of a human endothelial cell C1q receptor (C1qR). J Leukoc Biol (1993) 1.13
Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. J Clin Invest (1995) 1.11
Dual effect of HBO on cerebral infarction in MCAO rats. Am J Physiol Regul Integr Comp Physiol (2001) 1.08
Identification of a novel 33-kDa C1q-binding site on human blood platelets. J Immunol (1994) 1.08
The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization. Clin Immunol Immunopathol (1997) 1.08
Lysis of C1Q-coated chicken erythrocytes by human lymphoblastoid cell lines. J Immunol (1978) 1.04
Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin Immunol Immunopathol (1994) 1.02
Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol (1999) 0.99
C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. Biochem J (1998) 0.97
Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q. J Immunol (1996) 0.97
Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med (1993) 0.95
The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv Immunol (1997) 0.95
Potentiation of antiboty-dependent cell-mediated cytotoxicity by target cell-bound C3b. J Immunol (1979) 0.95
Parathyroid adenoma with primary hyperparathyroidism and tuberous sclerosis. A case report. Chin Med J (Engl) (1984) 0.95
Prevalence of Alzheimer's disease and other dementing disorders in an urban community of Beijing, China. Neuroepidemiology (2000) 0.94
Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunobiology (1998) 0.94
Microsatellite instability and K-ras mutations in gastric adenomas, with reference to associated gastric cancers. Cancer Detect Prev (1999) 0.93
Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation. Ann N Y Acad Sci (1982) 0.93
Mapping of human and murine genes for latent TGF-beta binding protein-2 (LTBP2). Mamm Genome (1995) 0.93
Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection. AIDS (1997) 0.93
Human blood platelets possess specific binding sites for C1q. J Immunol (1987) 0.93
Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice. Gene Ther (2007) 0.92
Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils. Blood (1994) 0.92
Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol (1983) 0.91
Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours. Eur J Cancer (2009) 0.91
Platelet C1q receptor interactions with collagen- and C1q-coated surfaces. J Immunol (1990) 0.90
Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937. J Immunol (1985) 0.90
Linear growth patterns in prepubertal children following liver transplantation. Am J Transplant (2009) 0.90
Smooth muscle and epithelial cells express specific binding sites for the C1q component of complement. Clin Immunol Immunopathol (1992) 0.89
Activation of the kinin-forming cascade on the surface of endothelial cells. Biol Chem (2001) 0.89
C1q receptor. Methods Enzymol (1987) 0.89
Characterisation of the rat and mouse homologues of gC1qBP, a 33 kDa glycoprotein that binds to the globular 'heads' of C1q. FEBS Lett (1997) 0.89
Effect of hyperbaric oxygen on striatal metabolites: a microdialysis study in awake freely moving rats after MCA occlusion. Brain Res (2001) 0.89
Trichinella spiralis: activation of complement by infective larvae, adults, and newborn larvae. Exp Parasitol (1992) 0.88
Reticuloendothelial system fc receptor function in rheumatoid arthritis. J Rheumatol (1983) 0.88
Molecular cloning of the mouse activin beta E subunit gene. Biochem Biophys Res Commun (1996) 0.88
Modulation of platelet responses to collagen by Clq receptors. J Immunol (1990) 0.88
Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore). Thromb Haemost (2011) 0.88
Structure, chromosomal localization, and expression pattern of the murine Magp gene. J Biol Chem (1993) 0.87
Liquid chromatography-mass spectrometry and proton nuclear magnetic resonance characterization of trace level condensation products formed between lactose and the amine-containing diuretic hydrochlorothiazide. J Pharm Sci (2000) 0.87
Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann Rheum Dis (2007) 0.87
Human C1q induces eosinophil migration. Clin Immunol Immunopathol (1996) 0.86
Gene mutation in patients with primary open-angle glaucoma in a pedigree in China. Chin Med J (Engl) (2000) 0.86
C1q inhibits the expression of B lymphoblastoid cell line interleukin 1 (IL 1). J Immunol (1987) 0.86
Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1. Thromb Haemost (2001) 0.86
The role of complement in cigarette smoke-induced chemotactic activity of lung fluids. Am Rev Respir Dis (1986) 0.85
Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology (1999) 0.85
Assessment of autofluorescence to detect the remineralization capabilities of sodium fluoride, monofluorophosphate and non-fluoride dentifrices. A single-blind cluster randomized trial. Caries Res (2007) 0.84
Participation of C1q and its receptor in adherence of human diploid fibroblast. J Immunol (1990) 0.83
Human blood platelet gC1qR/p33. Immunol Rev (2001) 0.82
The human gC1qR/p32 gene, C1qBP. Genomic organization and promoter analysis. J Biol Chem (2001) 0.82
Platelet membrane receptors for the complement component C1q. Semin Hematol (1994) 0.82
Characterization of the third component of complement (C3) after activation by cigarette smoke. Clin Immunol Immunopathol (1987) 0.82
C1q inhibitor (C1qINH): functional properties and possible relationship to a lymphocyte membrane-associated C1q precipitin. J Immunol (1981) 0.82
Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG. Clin Immunol Immunopathol (1992) 0.81
C1q augments platelet activation in response to aggregated Ig. J Immunol (1997) 0.81
The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Crit Rev Immunol (1981) 0.81
The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization. Clin Immunol (1999) 0.81
Bradykinin formation. Plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol (1998) 0.81
[Alkaloids of plumula Nelumbinis]. Zhongguo Zhong Yao Za Zhi (1991) 0.81
Complement component C1q and its receptor are involved in the interaction of human sperm with zona-free hamster eggs. Mol Reprod Dev (1991) 0.80
Blood pressure elevation in long-term survivors of pediatric liver transplantation. Am J Transplant (2011) 0.80
A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen. Arch Virol (2008) 0.80
Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR). J Immunol (1986) 0.80
Purification and partial characterization of a C1q inhibitor from the membranes of human peripheral blood lymphocytes. J Immunol (1982) 0.80
Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation. Transplant Proc (2004) 0.79
Detection of complement C1q receptors on human spermatozoa. J Reprod Immunol (1998) 0.79
Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures. Clin Immunol (2001) 0.79
Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen. Mol Med (1999) 0.79
Expression of functional cell surface C1-inactivator by U937 cells. Clin Immunol Immunopathol (1988) 0.79
Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer. Br J Cancer (2010) 0.79
Micro-computerized tomography assessment of fluorescence aided caries excavation (FACE) technology: comparison with three other caries removal techniques. Aust Dent J (2013) 0.79
Assignment of C1QBP encoding the C1q globular domain binding protein (gC1q-R) to human chromosome 17 band p13.3 by in situ hybridization. Cytogenet Cell Genet (1997) 0.79
Phylogeographical analysis of an estuarine fish, Salanx ariakensis (Osmeridae: Salanginae) in the north-western Pacific. J Fish Biol (2009) 0.79
Stage-dependent evaluation of microsatellite instability in gastric carcinoma with familial clustering. Cancer Epidemiol Biomarkers Prev (1997) 0.78
A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes. Allergy (2014) 0.78
Development of a cell-based assay for monitoring hepatitis C virus ns3/4a protease activity. Acta Virol (2008) 0.78
Complement C1q inhibits cellular spreading and stimulates adenylyl cyclase activity of fibroblasts. Clin Immunol Immunopathol (1998) 0.78
Identification and partial characterization of human platelet C1q binding sites. J Immunol (1988) 0.78